These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36046453)

  • 1. Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride.
    Thalluri C; Amin R; Mandhadi JR; Gacem A; Emran TB; Dey BK; Roy A; Alqahtani MS; Refat MS; Safi SZ; Alsuhaibani AM
    Biomed Res Int; 2022; 2022():2467574. PubMed ID: 36046453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
    Dhakal B; Thakur JK; Mahato RK; Rawat I; Rabin DC; Chhetri RR; Shah KP; Adhikari A; Pandey J
    ScientificWorldJournal; 2022; 2022():9618344. PubMed ID: 35645632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant.
    Kaur L; Bala R; Kanojia N; Nagpal M; Dhingra GA
    ISRN Pharm; 2014; 2014():242504. PubMed ID: 24944837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsemide Fast Dissolving Tablets: Development, Optimization Using Box-Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment.
    El-Shenawy AA; Ahmed MM; Mansour HF; Abd El Rasoul S
    AAPS PharmSciTech; 2017 Aug; 18(6):2168-2179. PubMed ID: 28050711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DESIGN AND IN VITRO EVALUATION OF ACRIVASTINE AS ORODISPERSIBLE TABLET USING DIRECT COMPRESSION METHOD.
    Naji GH; Al-Zheery WH; Fareed NY
    Wiad Lek; 2023; 76(1):170-174. PubMed ID: 36883506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016 May; 42(5):769-775. PubMed ID: 26275030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
    Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016; 42(5):769-75. PubMed ID: 26289005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fast disintegrating tablets of paracetamol prepared from a blend of croscarmellose sodium and Pleurotus tuber-regium powder.
    Eraga SO; Arhewoh MI; Akpan FE; Iwuagwu MA
    Pak J Pharm Sci; 2018 Nov; 31(6):2503-2508. PubMed ID: 30473524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of promethazine theoclate fast dissolving tablet using pore forming technology by 3-factor, 3-level response surface-full factorial design.
    Sharma S; Sharma N; Das Gupta G
    Arch Pharm Res; 2010 Aug; 33(8):1199-207. PubMed ID: 20803123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of directly compressible mebevarine tablets using superdisintegrant: A way to investigate quality atributes, in vitro release kinetics and stability profile.
    Siddiqui S; Naqvi GR; Ali H; Zafar F; Siddiqui S; Nawab A; Siddiqui T
    Pak J Pharm Sci; 2021 May; 34(3):915-924. PubMed ID: 34602414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
    Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P
    Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, development, and optimization of immediate release nateglinide tablets by factorial design.
    Pani NR; Nath LK; Bhunia B
    Drug Discov Ther; 2010 Dec; 4(6):453-8. PubMed ID: 22491311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.